Issue 6/2021

LAMC2 acts as a novel therapeutic target of cetuximab in laryngeal cancer

Qin-Ying Wang, Yong-Cai Liu,  Shui-Hong Zhou, Hai-Hong Chen

DOI: 10.4149/neo_2021_210421N549

Recent advances in the contribution of circRNAs to cisplatin chemotherapy resistance in cancers (1119 — 1131)

Chao Mu, Xiao-Lu Wang, Ying Ruan, Jia-Jia Sun,  Xin-Rong Hu,  Ying Cheng

DOI: 10.4149/neo_2021_210624N846

Research progress on the treatment of advanced prostate cancer with Olaparib (1132 — 1138)

Yi-Xin Su, Cheng-Feng Yu, Peng Xue, Lin-Lu Li, Kun-Min Xiao, Xue-Lei Chu,  Shi-Jie Zhu

DOI: 10.4149/neo_2021_210627N856

Single clonal glandular stem cells derived from human parotid glands do not attain malignant phenotype during long-term in vitro culture (1139 — 1146)

Jung-Hwa Moon, Hye-Ryun Kim, Jae-Yol Lim,  Young-Chang Lim

DOI: 10.4149/neo_2021_210302N272

SLC7A11 negatively associates with mismatch repair gene expression and endows glioblastoma cells sensitive to radiation under low glucose conditions (1147 — 1156)

Nan Hu, Wei-Hua Hu, Shao-Long Zhou, Zhuo Yang, Wu-Long Liang, Ru-Yi Yang, Ming-He Li, Zhou Jing, Zi-An Li,  Xu-Dong Fu,  Xin-Jun Wang

DOI: 10.4149/neo_2021_210327N410

microRNA-10a-5p overexpression suppresses malignancy of colon cancer by regulating human liver cancer fibroblasts (1157 — 1168)

Xuan Zheng, Jing-Wu Li, Yan-Kun Liu, Yi-Fu Ma, Jian-Hui Gan, Su-Gui Han, Jian Wang, Zhao-Yuan Wan, Jun Zhang, Yan Liu,  Yu-Feng Li,  Guang-Ling Zhang

DOI: 10.4149/neo_2021_210226N250

Photodynamic therapy of multidrug resistant leukemic murine cells by 3,6-bis(alkylthiourea)acridine hydrochlorides (1169 — 1180)

 Helena Paulíková, Alžbeta Cisáriková, Zuzana Bačová, Ladislav Janovec, Ján Imrich, Mário Šereš, Ľuba Hunáková

DOI: 10.4149/neo_2021_210324N390

Mere15, a novel polypeptide from Meretrix meretrix, inhibits proliferation and metastasis of human non-small cell lung cancer cells through regulating the PI3K/Akt/mTOR signaling pathway (1181 — 1189)

Biantiao Xu, Mingyue Guo, Li Ma, Ammad Farooqi, Linlin Wang, Gan Qiao, Minghua Liu, Ling Zuo, Hanlin Ye,  Xiukun Lin,  Shousong Cao

DOI: 10.4149/neo_2021_210509N628

Overexpression of BMP9 promotes ovarian cancer progression via Notch1 signaling (1190 — 1200)

Lijuan Yang, Yingying Bai, Chaihong Zhang, Junhong Du, Yuemei Cheng, Qinganzi Wang, Bo Zhang,  Yongxiu Yang

DOI: 10.4149/neo_2021_210326N404

NCAPG, mediated by miR-378a-3p, regulates cell proliferation, cell cycle progression, and apoptosis of oral squamous cell carcinoma through the GSK-3β/β-catenin signaling (1201 — 1211)

Jianing Li, Shiqun Sun, Jia Li, Xuetao Zhao, Zehua Li, Tong Sha,  Zhi Cui

DOI: 10.4149/neo_2021_210421N544

The matrix metalloproteinase gene family: a significant prognostic gene lineage correlated with immune infiltrates in laryngeal squamous cell carcinoma (1212 — 1224)

Chuan Yang, Huan Cao, Jian-Wang Yang, Tao Liu, Jian-Tao Wang,  Bao-Shan Wang

DOI: 10.4149/neo_2021_210511N643

LncRNA LINC00355 promotes EMT and metastasis of bladder cancer cells through the miR-424-5p/HMGA2 axis (1225 — 1235)

Wen-Jie Li, Gang Li, Zhong-Wen Liu, Zhi-Yong Chen,  Rong Pu

DOI: 10.4149/neo_2021_210427N574

Inhibiting endoplasmic reticulum stress mediated-autophagy enhances the pro-apoptotic effects of resveratrol derivative in colon cancer cells (1236 — 1244)

Lei Yu, Ji-Guang Hou, Yun-Feng Li, Yin Wang,  Ming Hong,  Yan-Ming Yang

DOI: 10.4149/neo_2021_210422N552

circRNA_0006470 promotes the proliferation and migration of gastric cancer cells by functioning as a sponge of miR-27b-3p (1245 — 1256)

Yejia Cui, Jin Cao, Shaolong Huang, Jinjun Ye, Haohai Huang, Dan Liao, Yufeng Yang, Aiping Yin, Wanchan Chen, Yelin Yao, Yingai He,  Rong Pu

DOI: 10.4149/neo_2021_210222N235

Xenogeneic fibroblasts inhibit the growth of the breast and ovarian cancer cell lines in co-culture (1265 — 1271)

 Lydia Usha, Oleksandra Klapko, Seby Edassery

DOI: 10.4149/neo_2021_210226N252

Multiplex immunohistochemistry indicates biomarkers in colorectal cancer (1272 — 1282)

Wen Zhang, Zheng-Ji Song, Bao-Yue Zhang, Jin-Li Wang, Qiang Guo,  Zhi-Wei Sun,  Hui Tang

DOI: 10.4149/neo_2021_210312N324

A metabolomic signature of FIGO stage I and II endometrial cancer (1283 — 1291)

Mingli Gu, Xin Chen, Yi Sun, Linguo Wang,  Huizhen Shu,  Cheng Qian

DOI: 10.4149/neo_2021_210306N288

Predictive model using hemoglobin, albumin, fibrinogen, and neutrophil-to-lymphocyte ratio to distinguish patients with colorectal cancer from those with benign adenoma (1292 — 1300)

 Roman Záhorec, Vítězslav Marek, Iveta Waczulikova, Tomáš Veselovský, Julius Palaj, Štefan Kečkéš, Štefan Durdík

DOI: 10.4149/neo_2021_210331N435

Identification of plasma SAA2 as a candidate biomarker for the detection and surveillance of non-small cell lung cancer (1301 — 1309)

Fa-Fu Zhang, Bin Han, Run-Hao Xu, Qing-Qing Zhu, Qi-Qi Wu, Hui-Min Wei,  Zhi-Lei Cui,  Shu-Lin Zhang,  Min-Jie Meng

DOI: 10.4149/neo_2021_210228N263

Expression and prognostic significance of the DNA damage response pathway and autophagy markers in gastric cancer (1310 — 1319)

Xin-Bo Xu, Nian-Shuang Li, Huan Wang, Yi Hu, Xi-Dong Wu, Jun-Bo Hong, Nong-Hua Lu,  Chuan Xie

DOI: 10.4149/neo_2021_210515N667

Development and validation of a multivariable predictive model for EGFR gene mutation status in patients with lung adenocarcinoma (1320 — 1330)

Yiping Shi, Qiongfang Zha, Qing Ye, Shan Xue, Huawei Wu, Daoqiang Tang,  Hui Qin,  Jing Zou

DOI: 10.4149/neo_2021_210425N567

Detection of therapeutically relevant and concomitant rare somatic variants in colorectal cancer (1331 — 1340)

Peter Mikolajcik,  Zora Lasabova, Dusan Loderer, Marian Grendar, Michal Kalman, Ivana Kasubova, Vincent Lucansky, Alexander Wiederhold, Juraj Marcinek, Tatiana Burjanivova, Eva Kudelova, Martin Vojtko, Adam Svec, Lukas Plank, Jan Janik, Ludovit Laca

DOI: 10.4149/neo_2021_210616N804

Risk factors of thrombosis in a cohort of 206 patients with BCR-ABL1 negative myeloproliferative neoplasms (1341 — 1350)

 Mohamed Aswad, Jarmila Kissova, Petra Ovesna, Miroslav Penka

DOI: 10.4149/neo_2021_210729N1068

A novel intensive conditioning regimen for allogeneic hematopoietic stem cell transplantation in the treatment of relapsed/refractory acute myeloid leukemia (1351 — 1358)

Yanling Sun, Jingwen Zhang, Bing Long, Xiangzhong Zhang, Ruijuan Wen,  Yi He,  Xudong Li

DOI: 10.4149/neo_2021_210426N573